| Print
MeiraGTx Holdings plc (MGTX)
Ordinary SharesNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Address
92 Britannia Walk
London
CYM
N1 7NQ
Forecast key dates
| Name | Key Date |
|---|---|
| MeiraGTx Holdings PLC Second Quarter Earnings Results for 2026 | 2026-08-14T00:00:00 |
| MeiraGTx Holdings PLC Annual General Meeting for 2026 | 2026-06-12T10:00:00 |
| MeiraGTx Holdings PLC First Quarter Earnings Results for 2026 | 2026-05-13T00:00:00 |
| MeiraGTx Holdings PLC Fourth Quarter Earnings Results for 2025 | 2026-03-13T00:00:00 |
| MeiraGTx Holdings PLC Annual Report for 2025 | 2026-03-13T00:00:00 |
| MeiraGTx Holdings PLC Third Quarter Earnings Results for 2025 | 2025-11-13T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| MeiraGTx Holdings PLC Second Quarter Earnings Results for 2025 | 2025-08-14T00:00:00 |
| MeiraGTx Holdings PLC Annual General Meeting for 2025 | 2025-06-12T10:00:00 |
| 46th Annual Goldman Sachs Global Healthcare Conference | 2025-06-09T10:00:00 |
| 2025 Bank of America Health Care Conference | 2025-05-14T08:55:00 |
| MeiraGTx Holdings PLC First Quarter Earnings Results for 2025 | 2025-05-13T00:00:00 |
| 2025 RBC Capital Makets Ophthalmology Conference | 2025-04-03T11:30:00 |
| MeiraGTx Holdings PLC Fourth Quarter Earnings Results for 2024 | 2025-03-13T00:00:00 |
| MeiraGTx Holdings PLC Annual Report for 2024 | 2025-03-13T00:00:00 |
| Piper Sandler 36th Annual Healthcare Conference | 2024-12-05T08:00:00 |
| Evercore 7th Annual HealthCONx Conference | 2024-12-03T10:00:00 |
| MeiraGTx Holdings PLC Third Quarter Earnings Results for 2024 | 2024-11-13T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.